What happens to the dosage when you switch
Bioavailability: Can You Actually Absorb What You Take
Nir Barzilai, a geroscientist and professor of genetics and medicine at the Albert Einstein College of Medicine, said GLP-1 drugs are among a handful of medications that appear to influence the hallmarks of aging, making them promising candidates for longevity therapy
Trust often starts with transparency
Semaglutide is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment, not weight loss
Immortalized cellular models provide controlled environments for investigating the molecular and neurochemical pathways involved in neuronal function, while iPSCs and brain organoids, derived from patient-specific sources, offer significant advantage in translational research by facilitating direct comparisons of cellular phenotypes between patient-derived neurons and healthy-control neurons